Annual report
4151.TEDINET S100T1DP
Period2023-01-01 → 2023-12-31
Filed2024-03-12
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 155
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥442.2bn | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥398.4bn | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥352.2bn | 2021-01-01 → 2021-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥318.4bn | 2020-01-01 → 2020-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥305.8bn | 2019-01-01 → 2019-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Profit before tax | ¥97.2bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥67.6bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥60.0bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥52.3bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥44.5bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥81.2bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥53.6bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥52.3bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥47.0bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥67.1bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥81.2bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥53.6bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥1.03T | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥939.9bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥921.9bn | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥801.3bn | at 2020-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥784.5bn | at 2019-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥189.5bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥177.1bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥836.4bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥762.8bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥737.2bn | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥836.4bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥762.8bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥737.2bn | at 2021-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥698.4bn | at 2020-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥678.3bn | at 2019-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥403.1bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥339.2bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥335.1bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥287.0bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥20.8bn | at 2019-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥115.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥48.7bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥86.5bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥39.5bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥53.7bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥20.4bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥17.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥11.4bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥252.6bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥933m | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥32.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥29.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥28.4bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥26.0bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥47.4bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥151.03 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥99.68 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥97.43 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥87.56 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥124.57 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥151.01 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥99.66 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥97.39 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥87.5 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥124.46 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,555.81 | at 2023-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,419.27 | at 2022-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,371.9 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,300.12 | at 2020-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,263.16 | at 2019-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 81.5% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 81.2% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 80.0% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 87.2% | at 2020-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 86.5% | at 2019-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 10.2% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 7.1% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 7.3% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.8% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 10.1% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 5,974 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 5,982 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 5,752 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 5,423 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 5,267 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥277.2bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥253.8bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥237.6bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥252.9bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥246.3bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥53.4bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥40.6bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥67.2bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥37.3bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥35.2bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥49.6bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥73.4bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥61.5bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥38.0bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | ¥50.4bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥31.0bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥66.4bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥31.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥91.5bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥869.6bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥806.1bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥794.1bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥687.7bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥618.3bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥246.9bn | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥204.1bn | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥622.7bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥601.9bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥596.9bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥555.7bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥549.0bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥12.4bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥11.3bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥93.7 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥57.77 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.52 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.18 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥169.85 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥93.69 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥57.75 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥123.47 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥58.15 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥169.71 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥56 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥51 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥46 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥44 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,158.1 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,119.48 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,110.13 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,033.43 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,021.09 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 71.6% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.6% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.1% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.7% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.7% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.2% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.2% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.1% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.7% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.4% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 540,000,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 540,000,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 540,000,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 540,000,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 540,000,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4,082 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 4,002 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 3,857 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 3,736 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 3,619 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceuticalsreportable segment | employees | at 2023-12-31 | 5974 pure |
| Pharmaceuticalsreportable segment | employees | at 2023-12-31 | 4082 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,826
| Item | Context | Value | Unit |
|---|---|---|---|
| Goodwill IFRS | Prior1YearInstant | 135761000000 | JPY |
| In process research and development IFRS | Prior1YearInstant | 33248000000 | JPY |
| Marketing rights IFRS | Prior1YearInstant | 24698000000 | JPY |
| Other components of intangible assets IFRS | Prior1YearInstant | 6840000000 | JPY |
| Intangible assets IFRS | Prior1YearInstant | 64786000000 | JPY |
| Goodwill IFRS | CurrentYearInstant | 140450000000 | JPY |
| In process research and development IFRS | CurrentYearInstant | 22191000000 | JPY |
| Marketing rights IFRS | CurrentYearInstant | 33090000000 | JPY |
| Other components of intangible assets IFRS | CurrentYearInstant | 7637000000 | JPY |
| Intangible assets IFRS | CurrentYearInstant | 62918000000 | JPY |
| Goodwill acquisition cost IFRS | Prior1YearInstant | 135761000000 | JPY |
| In process research and development acquisition cost IFRS | Prior1YearInstant | 56035000000 | JPY |
| Marketing rights acquisition cost IFRS | Prior1YearInstant | 107497000000 | JPY |
| Other components of intangible assets acquisition cost IFRS | Prior1YearInstant | 12562000000 | JPY |
| Intangible assets acquisition cost IFRS | Prior1YearInstant | 176094000000 | JPY |
| Goodwill acquisition cost IFRS | CurrentYearInstant | 140450000000 | JPY |
| In process research and development acquisition cost IFRS | CurrentYearInstant | 35607000000 | JPY |
| Marketing rights acquisition cost IFRS | CurrentYearInstant | 128793000000 | JPY |
| Other components of intangible assets acquisition cost IFRS | CurrentYearInstant | 15631000000 | JPY |
| Intangible assets acquisition cost IFRS | CurrentYearInstant | 180031000000 | JPY |
| Goodwill accumulated impairment losses IFRS | Prior1YearInstant | － | JPY |
| In process research and development accumulated amortization and impairment losses IFRS | Prior1YearInstant | -22788000000 | JPY |
| Marketing rights accumulated amortization and impairment losses IFRS | Prior1YearInstant | -82799000000 | JPY |
| Other components of intangible assets accumulated amortization and impairment losses IFRS | Prior1YearInstant | -5721000000 | JPY |
| Intangible assets accumulated amortization and impairment losses IFRS | Prior1YearInstant | -111308000000 | JPY |
| Goodwill accumulated impairment losses IFRS | CurrentYearInstant | － | JPY |
| In process research and development accumulated amortization and impairment losses IFRS | CurrentYearInstant | -13416000000 | JPY |
| Marketing rights accumulated amortization and impairment losses IFRS | CurrentYearInstant | -95704000000 | JPY |
| Other components of intangible assets accumulated amortization and impairment losses IFRS | CurrentYearInstant | -7994000000 | JPY |
| Intangible assets accumulated amortization and impairment losses IFRS | CurrentYearInstant | -117114000000 | JPY |
| Raw materials and supplies ca IFRS | Prior1YearInstant | 13484000000 | JPY |
| Raw materials and supplies ca IFRS | CurrentYearInstant | 13928000000 | JPY |
| Work in process ca IFRS | Prior1YearInstant | 15936000000 | JPY |
| Work in process ca IFRS | CurrentYearInstant | 13564000000 | JPY |
| Merchandise and finished goods ca IFRS | Prior1YearInstant | 41254000000 | JPY |
| Merchandise and finished goods ca IFRS | CurrentYearInstant | 43870000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 70675000000 | JPY |
| Inventories ca IFRS | CurrentYearInstant | 71363000000 | JPY |
| Employee benefit expenses sga IFRS | Prior1YearDuration | 66327000000 | JPY |
| Employee benefit expenses sga IFRS | CurrentYearDuration | 73674000000 | JPY |
| Sales promotion expenses IFRS | Prior1YearDuration | 47333000000 | JPY |
| Sales promotion expenses IFRS | CurrentYearDuration | 29845000000 | JPY |
| Depreciation and amortization sga IFRS | Prior1YearDuration | 10093000000 | JPY |
| Depreciation and amortization sga IFRS | CurrentYearDuration | 10405000000 | JPY |
| Other sga IFRS | Prior1YearDuration | 42431000000 | JPY |
| Other sga IFRS | CurrentYearDuration | 49154000000 | JPY |
| Selling general and administrative expenses IFRS | Prior1YearDuration | 166185000000 | JPY |
| Selling general and administrative expenses IFRS | CurrentYearDuration | 163078000000 | JPY |
| Gain on sales of share and valuation of remaining share other income IFRS | Prior1YearDuration | － | JPY |
| Gain on sales of share and valuation of remaining share other income IFRS | CurrentYearDuration | 14799000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |